Janku Filip
Chief Medical Officer · 11 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 5,407 | $24.50 | $132,471.50 | filing |
| 2026-06-30 | GLUE | Monte Rosa Therapeutics, Inc. | Option exercise | 5,407 | $13.41 | $72,507.87 | filing |
| 2026-06-29 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 6,000 | $22.95 | $137,700.00 | filing |
| 2026-06-29 | GLUE | Monte Rosa Therapeutics, Inc. | Option exercise | 6,000 | $7.56 | $45,360.00 | filing |
| 2026-06-24 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 30,000 | $21.42 | $642,681.00 | filing |
| 2026-06-24 | GLUE | Monte Rosa Therapeutics, Inc. | Option exercise | 30,000 | $7.56 | $226,800.00 | filing |
| 2026-06-23 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 11,845 | $20.22 | $239,522.48 | filing |
| 2026-06-23 | GLUE | Monte Rosa Therapeutics, Inc. | Option exercise | 6,000 | $7.56 | $45,360.00 | filing |
| 2026-02-23 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 9,189 | $19.50 | $179,160.69 | filing |
| 2026-01-05 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 3,155 | $15.17 | $47,861.35 | filing |
| 2026-01-02 | GLUE | Monte Rosa Therapeutics, Inc. | Award | 31,000 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.